Skip to main content
Clinical Case Reports logoLink to Clinical Case Reports
. 2022 Dec 5;10(12):e6676. doi: 10.1002/ccr3.6676

Pneumonia in the presentation of Kawasaki disease: The syndrome or a sequence of two diseases?

Lana Khoury 1, Galit Livnat 2,3, Mohamad Hamad Saied 4, Karin Yaacoby‐Bianu 2,
PMCID: PMC9723393  PMID: 36483871

Abstract

Two cases of Kawasaki disease (KD) presented as persistent lung consolidation associated with Group A Streptococcus and Influenza A co‐infection, which resolved following intravenous immunoglobulin. Thus, pediatricians should consider the diagnosis of KD in the presence of pneumonia that is nonresponsive to antibiotic therapy with prolonged fever and inflammatory reactions.

Keywords: case report, Influenza, Kawasaki disease, pulmonary involvement, Streptococcus

1. BACKGROUND

Kawasaki disease (KD) is a medium vessel multi‐systemic vasculitis that predominantly affects children younger than 5 years old. 1 The diagnosis of classic KD is based on the presence of ≥5 days of fever and ≥4 of five principal clinical features: polymorphous exanthem, extremity changes, mucosal involvement of the lips and oral cavity, bilateral non‐purulent conjunctivitis, and unilateral cervical lymphadenopathy. 2 These criteria unfortunately do not identify all children with the illness. Therefore, patients who do not have sufficient clinical findings can be diagnosed with incomplete or atypical KD by fulfilling some of the typical criteria with other clinical, laboratory, or echocardiographic findings. 3 The reported prevalence of incomplete presentation is 15 to 36.2% among patients with KD. 4 , 5 There is no definitive diagnostic test for KD, thus accurate and timely diagnosis of KD is challenging for clinicians.

The etiology of KD remains unclear, though various hypotheses regarding the role of an infectious trigger and bacterial super antigens have been postulated. 2 Although inflammation of the coronary arteries is the most dreaded clinical outcome, KD is characterized by systemic inflammation in all medium‐sized arteries and in multiple organs and tissues during the acute febrile phase, 6 leading to increased vascular permeability and associated clinical findings.

The pulmonary manifestations of KD may be diverse but are distinctly uncommon and often unrecognized. Careful monitoring is essential because some features of KD may evolve over time. Early identification of patients who have pulmonary presentation may prevent delays in diagnosis and allow early initiation of appropriate therapy. Singh et al, 7 showed that only 1.83% of children diagnosed with KD (11/602) had a predominant pulmonary presentation, and the first sign of KD was noted at a mean duration of 14.5 days from the onset of symptoms. Lee et al, 8 in the largest cohort of KD patients with pulmonary involvement, reported 15% with concurrent pneumonia (54/358).

Chest radiological findings in patients with KD are uncommon (~20%) in the acute phase and may include an interstitial pattern, alveolar infiltrates, subsegmental atelectasis, and pleural effusion. 9

In this article, we report two cases of KD presenting as pneumonia associated with GAS and Influenza A co‐infection that were admitted to the Pediatric Department in Carmel Medical Center, Haifa, Israel, in February 2019 and January 2020, respectively.

2. CASE PRESENTATIONS

2.1. Case 1

A previously healthy and immunized 15‐month‐old girl presented with a 4 days history of fever, coughing, and vomiting. On the second day of fever, a rash was described. On admission to the emergency room (ER) she was weak, pale, and sleepy. Vital signs were 147 beats per minute, temperature 37.9°C, respiratory rate 32 per minute, and oxygen saturation 98% in room air. On physical examination, she had a diffused rash, pealing on the face and lips, signs of left otitis media, clear lung sounds, normal heart auscultation other than tachycardia. There were no meningeal signs or papilledema. Initial laboratory blood results (Table 1) revealed minimally elevated white blood cell count, mildly low hemoglobin level, normal platelet count, and elevated inflammatory markers: C‐reactive protein (CRP) 24 mg/dL and erythrocyte sedimentation rate (ESR) of 48 mm/h. Due to her ill appearance, she underwent a lumbar puncture (Table 1), with no signs of infection.

TABLE 1.

Laboratory results

Case 1 Case 2 Normal range
At the day of admission At the 10th day of fever At the day of admission
Blood
WBC (k/μL) 11.09 21 11.6 1–32 months (6–14) 2–9 years (4–12)
ANC (k/μL) 10.31 9.24 9.35 3–5.8
Hb (g/dl) 10.8 8.8 10.5 1–32 months (10.5–14) 2–9 years (11.5–14.5)
Platelets (k/μL) 359 1025 423 150–400
Na (mEq/l) 130 138 132 134–144
K (mEq/l) 3.8 5.4 (hemolytic) 4.2 3.3–4.6
Creatinine (mg/dL) 0.48 0.13 0.42 0.03–0.5
Urea (mg/dL) 39 17 16 5–18
AST (U/L) 80 16 23 20–60
ALT (U/L) 52 9 6 5–45
ALP (U/L) 1600 810 83 145–420
GGT (U/L) 15 17 9 5–32
LDH (U/L) 1018 532 590 150–500
Albumin (g/dL) 2.7 3.4–4.2
Ferritin (ng/mL) 412 10–60
CRP (mg/dL) 24 16 9.6 0.08–0.79
ESR (mm/h) 48 90 0–10
CSF Two days following admission
WBC (cells/μL) 2 1 0–5
RBC (cells/μL) 4 45 0
Glucose (mg/dL) 107 122 >50
Protein (mg/dL) 9 10 <45
Pleural fluid
WBC (cells/μL) 720
Segments percentage (out of total WBC) 60%
pH 7.51
Glucose (mg/dL) 41
LDH (blood at same time) (mg/dL) 2829 (715)
Protein (blood at same time) (mg/dL) 4.2 (6.7)

Abbreviations: ALP, alkaline phosphatase; ALT, alanine transaminase; ANC, absolute neutrophilic count; AST, aspartate transaminase; CRP, C‐reactive protein; ESR, erythrocyte sedimentation rate; GGT, gamma‐glutamyl transferase; Hb, hemoglobin; K, potassium; LDH, lactic dehydrogenase; Na, sodium; pH, power of hydrogen; RBC, red blood cells; WBC, white blood cells.

Bold values are values above or below the normal range for that value.

An anteroposterior chest X‐ray (CXR) (Figure 1A) showed blurring of the left diaphragm that was interpreted as left lower lobe (LLL) pneumonia. In addition, she was found to be Influenza A positive by a multiplex respiratory viruses polymerase chain reaction (PCR). She was started on a third generation Cephalosporin plus Oseltamivir for 5 days and was admitted to the pediatric department.

FIGURE 1.

FIGURE 1

Chest X‐rays of case 1

Bacterial cultures from blood, urine, and CSF were negative. On the third day following admission, a second CXR (Figure 1B) was performed and revealed a LLL consolidation with mild pleural effusion. Chest US supported the findings and revealed left moderate pleural effusion with growing septations on follow ups. Therefore, Clindamycin was added in combination with Ceftriaxone. Further workout ruled out RSV, Metapneumovirus, Rhino virus, Adeno virus, Parainfluenza 1/2/3, Measles, EBV, CMV, and Enterovirus infections. The patient underwent thoracentesis to characterize the pleural effusion on the 5th day (Figure 1C). Forty ml of sero‐bloody fluid were drained. The laboratory findings of the fluid (Table 1) were compatible with exudative pleural effusion according to Light's criteria. 10 PCR from Pleural fluid revealed Streptococcus pyogenes.

On the 10th day of fever, despite administration of wide‐spectrum antibiotics, Oseltamivir and thoracentesis, the child continued to appear ill and irritable. On physical examination, a strawberry tongue was observed, in addition to a pealing rash on her face, chest and genitalia. Repeated blood samples (Table 1) showed an elevation of acute phase reactants (ESR 90) and an extremely elevated thrombocyte count, up to 1025 K/ul.

A diagnosis of Incomplete Kawasaki was made by fulfilling the criteria of polymorphous exanthem, mucosal involvement of the oral cavity, elevated inflammatory markers, and laboratory findings: anemia, elevated platelets count, elevated white blood cell (WBC) count, and low albumin. The patient received a dose of 2 g/kg of intravenous immunoglobulin (IVIG), with immediate relief of fever and improvement in her general condition. Periungual desquamation of hands developed later. Aspirin was not administered due to risk of Reye Syndrome during active infection with Influenza A. Instead, nonsteroidal anti‐inflammatory drugs (NSAID's, Ibuprofen 10 mg/Kg X3/day) were administered as an anti‐inflammatory agent. She completed 3 weeks of antibiotics (switched to oral Amoxicillin when she clinically improved).

Heart Echocardiogram was obtained on admission and was normal. On the 10th day of fever, it showed mild to moderate pericardial effusion which resolved on Day 14, with intact coronary arteries at pediatric cardiology follow‐up during the following 2 months. No pulmonary or cardiology sequelae were evident after one‐year of follow‐up.

2.2. Case 2

A previously healthy and immunized 28‐month‐old girl presented with a 3 days history of fever, coughing, rhinorrhea, and vomiting. The parents described a sleepy child with no appetite. A chest X‐ray performed on the second day of fever was normal.

On admission to the ER, she appeared ill, tachycardic with 156 beats per minute, had normal blood pressure, temperature of 38.6°C, oxygen saturation 98% in room air. On physical examination, she had no meningeal signs, a diffuse maculopapular rash was noticed on her face, chest, and back. Erythematous, swollen tonsils were noticed with no white exudate or cervical lymphadenopathy. On lung auscultation, decreased air entry over the left lung was heard, without crackles or wheezing. Initial laboratory blood results (Table 1) revealed an elevated white blood cell count, minimally elevated platelet count, and elevated CRP 9.6 mg/dL. CXR showed bilateral peri‐hilar peri‐bronchial thickening. Influenza A was positive by a multiplex respiratory viruses PCR. She was admitted to the pediatric department with Oseltamivir treatment, for further evaluation and supportive care.

Two days following admission, she was lethargic; LP was performed and was normal (Table 1). Bacterial cultures from blood and CSF and serology for EBV and CMV were negative. Physical examination revealed pus eruption from her left ear, and crackles were heard over the lower part of the left lung. Thus, a second CXR was performed, which revealed LLL consolidation. In addition, a throat culture and an exudate ear culture were both positive for group AStreptococci (GAS). In order to treat the lobar pneumonia, purulent otitis media, and GAS tonsillitis, she was started on a third generation Cephalosporin in addition to Oseltamivir.

On the 4th day of hospitalization (7th day of fever), new signs on physical examination were found, including cervical lymphadenopathy, red swollen lips with strawberry tongue, extremity edema, pealing perineal skin, and a rash that was described at admission. Laboratory examination revealed CRP 19 mg/dL, ESR 78 mm/h, albumin 2.6 g/dL, and platelet count of 562 K/ul. Heart echocardiogram was performed and was normal.

A diagnosis of complete Kawasaki was made by fulfilling the criteria of polymorphous exanthem, extremity changes, mucosal involvement of the lips and oral cavity, and unilateral cervical lymphadenopathy. The patient received 2 g/kg of IVIG, with decrement of fever. Thirty‐six hours following the end of the IVIG infusion the fever relapsed. Our assumption was that she had KD with first dose IVIG resistance. On the contrary, the patient was persistently lethargic therefore to rule out a brain abscess, a CT scan of the brain was done and was normal. A second dose of IVIG was administered, and immediate relief of fever was observed. In addition, she was treated with NSAID's (Ibuprofen 10 mg/Kg X3/day) as an anti‐inflammatory agent, and Aspirin as an anti‐thrombotic, especially since her platelet count was elevated up to 1111 K/ul. She completed a week of Ceftriaxone and then 10 days of Amoxicillin. The pediatric cardiology follow‐up visits over the next 2 months were all normal. Aspirin administration was stopped 6 weeks after the diagnosis. No pulmonary or cardiology sequelae were evident after one‐year of follow‐up.

3. DISCUSSION

We reported on two cases of KD that presented with pulmonary involvement which is an uncommon presentation of KD. These children with predominant pulmonary manifestations often have a significant delay in diagnosis, since the patient has a “source” of infection in the CXR, and the physician attributes the fever and the ill appearance to a lung infection.

In order to diagnose these deceptive cases, the physician should have a high index of suspicion especially in cases where the patient does not respond to conventional treatment with antimicrobials, and the patient has persistent fever and ill appearance together with elevated inflammatory markers. In these types of cases, a diagnosis of inflammatory disease such as KD is a possibility in the differential diagnosis whether it is a typical or an atypical disease.

Arslanoglu Aydin et al., 11 in a recent review of 16 articles identified only 20 patients with pleural effusion due to KD, and only 11 of them presented with respiratory symptoms. Was KD triggered by the infection of the pleural space, or were the pulmonary findings features of the inflammation of KD? These are questions that should be investigated further by examining more cases of KD with pleural effusion.

The two cases described, are associated with GAS and influenza A co‐infection. The etiology of KD remains unclear, and no consistent association between any infectious agent and KD has been demonstrated to date, more than half a century since the discovery of KD. While approximately 35% of children with KD have a concurrent infection, 12 the presence of infection does not rule out the diagnosis of KD and ascribing the fever to such an infection or to KD requires clinical judgment.

In an English language literature search, only two case reports were found 13 , 14 describing the comorbidity of atypical KD and GAS pleural effusion in healthy children. Regarding Influenza A with concomitant KD there are two case reports. 15 , 16 Table 2 shows a comparison between our two cases and these four cases.

TABLE 2.

Comparison between the two reported cases of KD (GAS and influenza A co‐infection) and cases with influenza or Streptococcus only infections

Case 1 Case 2 Influenza and KD Joshi et al. (15) Influenza and KD Wang et al (16) Strep and KD Hendaus et al (13) Strep and KD Leahy et al. (14)
Pathogen GAS and influenza A GAS and influenza A influenza A (H1N1/09) influenza A (H1N1) GAS GAS
Age (years) 1 2 5 1 3 3
Gender F F M M F M
Cough + + + + + +
Respiratory Rate (per minute) 32 24 38 50
Heart Rate (bpm) 147 156 122 138 130 190
Oxygen Saturation 98% 98% 99% 94% 90% (on 2 L oxygen)
Duration of fever till diagnosis (days) 10 7 9 7 13 14
Examination findings suggestive of KD:
(a) Polymorphous exanthem + + + +
(b) Mucosal involvement + + +
(c) Bilateral non‐purulent conjunctivitis +
(d) Cervical lymphadenopathy + +
(e) Extremity changes Late desquamation + + + Late desquamation Late desquamation
WBC (10^9/L) 11 11.6 16.1 11.1 24 30.1
Platelets count (10^9/L) 359 423 191 195 206 804
CRP (mg/L) 240 96 148 >50 100 214
ESR (mm/min) 48 134 69 65 103
Treatment IVIG 2 doses of IVIG IVIG IVIG IVIG IVIG
Echo findings during the acute phase Mild to moderate pericardial effusion Normal Normal The inner diameter of the left main coronary artery was dilated, and the double coronary artery was not smooth. Prominent left anterior descending artery and left main coronary artery Prominent left anterior descending artery and left main coronary artery
Echo findings following 2 months Normal Normal Normal Normal Normal Persistent dilation of the left anterior descending artery and left main coronary artery
Chest X‐Ray findings LLL consolidation with mild pleural effusion LLL consolidation Minor peribronchial wall thickening bilaterally but no focal collapse or consolidation Normal Right middle and lower lobar consolidation with moderate pleural effusion Large right‐sided, lower lobe pneumonia with associated loculated pleural effusion

In a retrospective study 17 that reported a 4.8% rate of KD with concomitant Influenza, patients in the KD and Flu group exhibited longer time to KD diagnosis, longer duration of fever, and higher CRP and ESR values compared with patients in the only Flu or only KD groups. 17 To the best of our knowledge, this is the first description of cases of KD with GAS and influenza A co‐infection. Influenza infection is potently immunomodulatory at the bronchial epithelial surface, leading to sustained desensitization to subsequent pathogen challenge and is associated with changes in bacterial colonization patterns. 18 , 19 This supports the hypothesis that the development of KD is dependent on a permissive genetic and environmental host phenotype that may be facilitated by previous or concurrent infection. Hence, the potential contribution of GAS and influenza co‐infection to KD etiology requires further study.

Atypical clinical course and infectious‐like manifestations can cause delays in the accurate diagnosis and treatment of KD. The lack of response to prolonged wide spectrum parenteral antibiotic treatment and the complete response to IVIG also support the diagnosis of KD. In general, IVIG should be initiated as early as possible, within the first 10 days of fever onset as soon as the diagnosis can be established. Timely treatment is necessary in order to decrease the risk of coronary artery lesions which may develop in ∼15–25% of untreated children and may lead to ischemic heart disease or sudden death. 1 Indeed, in these two cases no cardiac aneurisms were reported in the cardiologic follow‐up, perhaps due to the relatively early IVIG treatment.

Two dilemmas arose while treating these two patients. The first is whether to continue the administration of antibiotics after the diagnosis of KD. Both patients were treated with wide spectrum antibiotics and there was no reduction of fever. Therefore, if the pulmonary manifestation is a total KD presentation, there is no need for treating the patient with antibiotics. On the contrary, bacterial super‐antigens have been associated with the development of KD, 20 therefore, KD may be a post infectious manifestation. Thus, treating the patient with antibiotics may be essential. In these two cases we decided to treat the patients with a full antibiotic regime for bacterial pneumonia.

The second dilemma was the use of high dose aspirin as an anti‐inflammatory agent as part of KD treatment. Reye syndrome is a non‐inflammatory encephalopathy associated with fatty degeneration of the liver, 21 and it may occur in children receiving aspirin while experiencing active infection with varicella or influenza. 22 Therefore, in a patient who presents with influenza A and KD, administration of high‐dose IVIG with NSAIDs, without high dose (anti‐inflammatory) aspirin should be considered. Amarilyo et al. found no significant clinical benefit in using IVIG with high dose Aspirin in KD compared with IVIG with low dose Aspirin. 23 Therefore, it was reasonable for us to treat the inflammatory phase of KD with NSAIDs rather than Aspirin in combination with IVIG in order to eliminate the risk for Reye syndrome.

4. CONCLUSIONS

KD requires a high index of suspicion and awareness of its unusual presentations. In our cases, KD mimicked pneumonia that was nonresponsive to antibiotic therapy with prolonged inflammatory reaction. Thus, KD should be included in the differential diagnosis by pediatricians in patients with febrile pneumonia who do not respond to antibiotics. This can prevent delay in diagnosis, shorten the hospital stay and prevent detrimental sequelae. The potential mechanism underlying pathogen infection‐mediated KD requires further investigation, which may provide scientific evidence for the pathogenesis of KD.

AUTHOR CONTRIBUTIONS

Galit Livnat: Writing – review and editing.

CONFLICT OF INTEREST

The authors declare that they have no competing interests.

ETHICAL APPROVAL

Not applicable.

CONSENT

Written informed consent for publication was obtained from the parents of both cases (including images which are entirely unidentifiable).

ACKNOWLEDGMENTS

None.

Khoury L, Livnat G, Hamad Saied M, Yaacoby‐Bianu K. Pneumonia in the presentation of Kawasaki disease: The syndrome or a sequence of two diseases? Clin Case Rep. 2022;10:e06676. doi: 10.1002/ccr3.6676

Lana Khoury, Galit Livnat, Equal contribution.

DATA AVAILABILITY STATEMENT

Data sharing not applicable to this article as no datasets were generated or analyzed during the current article.

REFERENCES

  • 1. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long‐term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927‐e999. doi: 10.1161/CIR.0000000000000484 [DOI] [PubMed] [Google Scholar]
  • 2. Son MBSR. Kawasaki Disease. In: Petty RE, Laxer RM, Lindsley CBWL, eds. Textb. Pediatr. Rheumatol. Elsevier Saunders; 2015:467‐483. [Google Scholar]
  • 3. De Graeff N, Groot N, Ozen S, et al. European consensus‐based recommendations for the diagnosis and treatment of Kawasaki disease‐the SHARE initiative. Rheumatol (United Kingdom). 2019;58:672‐682. doi: 10.1093/rheumatology/key344 [DOI] [PubMed] [Google Scholar]
  • 4. Witt MT, Minich LL, Bohnsack JF, Young PC. Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria. Pediatrics. 1999;104(1):e10. doi: 10.1542/PEDS.104.1.E10 [DOI] [PubMed] [Google Scholar]
  • 5. Barone SR, Pontrelli LR, Krilov LR. The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: use of clinical features and a rapid direct fluorescent antigen test. Arch Pediatr Adolesc Med. 2000;154:453‐456. doi: 10.1001/ARCHPEDI.154.5.453 [DOI] [PubMed] [Google Scholar]
  • 6. Amano S, Hazama F, Kubagawa H, Tasaka K, Haebara H, Hamashima Y. General pathology of Kawasaki disease: on the morphological alterations corresponding to the clinical manifestations. Pathol Int. 1980;30:681‐694. doi: 10.1111/j.1440-1827.1980.tb00966.x [DOI] [PubMed] [Google Scholar]
  • 7. Singh S, Gupta A, Jindal AK, et al. Pulmonary presentation of Kawasaki disease—a diagnostic challenge. Pediatr Pulmonol. 2018;53:103‐107. doi: 10.1002/ppul.23885 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Lee MN, Cha JH, Ahn HM, et al. Mycoplasma pneumoniae infection in patients with Kawasaki disease. Korean J Pediatr. 2011;54:123. doi: 10.3345/kjp.2011.54.3.123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Monedero Picazo MD, Fernández‐Montes JG, Molina Fábrega R, Vallcanera Calatayud A, Alabau Vázquez G, Revert Ros MA. Radiologic findings in the lungs of patients with Kawasaki disease. Radiologia. 2006;48:14‐18. doi: 10.1016/S0033-8338(06)73124-1 [DOI] [PubMed] [Google Scholar]
  • 10. McGraw MD, Robison K, Kupfer O, Brinton JT, Stillwell PC. The use of light's criteria in hospitalized children with a pleural effusion of unknown etiology. Pediatr Pulmonol. 2018;53:1101‐1106. doi: 10.1002/ppul.24065 [DOI] [PubMed] [Google Scholar]
  • 11. Arslanoglu Aydin E, Demir S, Aydin O, Bilginer Y, Ozen S. Pleural effusion as an atypical presentation of Kawasaki disease: a case report and review of the literature. J Med Case Reports. 2019;13(1):344. doi: 10.1186/s13256-019-2284-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Fernández‐Cooke E, Tascón AB, Antón‐López J, Grasa Lozano CD, Sánchez‐Manubens J, Calvo C. Previous or coincident infections with suspected Kawasaki disease. Should we change our approach? An Pediatría (Engl Ed). 2019;90:213‐218. doi: 10.1016/J.ANPEDE.2018.06.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Hendaus M, Alhammadi A. Comorbidity of Kawasaki disease and group a streptococcal pleural effusion in a healthy child: a case report. Int J Gen Med. 2013;6:613‐616. doi: 10.2147/ijgm.s49510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Leahy TR, Cohen E, Allen UD. Incomplete Kawasaki disease associated with complicated streptococcus pyogenes pneumonia: a case report. Can J Infect Dis Med Microbiol = J Can des mal Infect La Microbiol Medicale. 2012;23:137‐139. doi: 10.1155/2012/638357 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Joshi AV, Jones KDJ, Buckley AM, Coren ME, Kampmann B. Kawasaki disease coincident with influenza a H1N1/09 infection. Pediatr Int. 2011;53:e1‐e2. doi: 10.1111/j.1442-200X.2010.03280.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Wang J, Sun F, Deng HL, Liu RQ. Influenza a (H1N1) pdm09 virus infection in a patient with incomplete Kawasaki disease: a case report. Medicine (Baltimore). 2019;98:e15009. doi: 10.1097/MD.0000000000015009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Huang X, Huang P, Zhang L, et al. Influenza infection and Kawasaki disease. Rev Soc Bras Med Trop. 2015;48:243‐248. doi: 10.1590/0037-8682-0091-2015 [DOI] [PubMed] [Google Scholar]
  • 18. Wadowsky RM, Mietzner SM, Skoner DP, Doyle WJ, Fireman P. Effect of experimental influenza a virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects. Infect Immun. 1995;63:1153‐1157. doi: 10.1128/iai.63.4.1153-1157.1995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Short KR, Habets MN, Hermans PWM, Diavatopoulos DA. Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship? Future Microbiol. 2012;7:609‐624. doi: 10.2217/fmb.12.29 [DOI] [PubMed] [Google Scholar]
  • 20. Leung DYM. Superantigens related to Kawasaki syndrome. Springer Semin Immunopathol. 1996;17:385‐396. doi: 10.1007/BF01795136 [DOI] [PubMed] [Google Scholar]
  • 21. Reye RDK, Morgan G, Baral J. Encephalopathy and fatty degeneration of the viscera. a disease entity in childhood. Lancet. 1963;282:749‐752. doi: 10.1016/S0140-6736(63)90554-3 [DOI] [PubMed] [Google Scholar]
  • 22. Takahashi M, Mason W. Kawasaki syndrome, Reye syndrome, and aspirin. Pediatrics. 1986;77:616‐617. [PubMed] [Google Scholar]
  • 23. Amarilyo G, Koren Y, Brik Simon D, et al. High‐dose aspirin for Kawasaki disease: outdated myth or effective aid? Clin Exp Rheumatol. 2017;35(Suppl. 103):209‐212. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data sharing not applicable to this article as no datasets were generated or analyzed during the current article.


Articles from Clinical Case Reports are provided here courtesy of Wiley

RESOURCES